Integral Ad Science (NASDAQ:IAS) Sets New 1-Year High After Analyst Upgrade

Integral Ad Science Holding Corp. (NASDAQ:IASGet Free Report) hit a new 52-week high during trading on Thursday after Barclays raised their price target on the stock from $20.00 to $21.00. The stock traded as high as $20.29 and last traded at $19.77, with a volume of 244739 shares changing hands. The stock had previously closed at $19.80.

Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus raised their price target on Integral Ad Science from $15.00 to $19.00 in a report on Monday, April 24th. Raymond James raised their price target on Integral Ad Science from $19.00 to $23.00 in a report on Wednesday, June 14th. Piper Sandler raised their price target on Integral Ad Science from $21.00 to $23.00 in a report on Friday, July 14th. KeyCorp initiated coverage on Integral Ad Science in a research note on Wednesday, April 12th. They issued a “sector weight” rating on the stock. Finally, Benchmark started coverage on Integral Ad Science in a research note on Tuesday, June 6th. They issued a “hold” rating on the stock. Three investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $18.64.

Insider Transactions at Integral Ad Science

In other Integral Ad Science news, major shareholder Vep Group, Llc sold 5,220,000 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $18.13, for a total value of $94,638,600.00. Following the sale, the insider now owns 77,660,001 shares in the company, valued at approximately $1,407,975,818.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, major shareholder Vep Group, Llc sold 5,220,000 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $18.13, for a total transaction of $94,638,600.00. Following the sale, the insider now owns 77,660,001 shares in the company, valued at approximately $1,407,975,818.13. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Tom Sharma sold 9,646 shares of the stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $17.41, for a total value of $167,936.86. Following the completion of the sale, the insider now directly owns 45,393 shares of the company’s stock, valued at $790,292.13. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,772,462 shares of company stock valued at $268,029,774. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Integral Ad Science

Several hedge funds have recently made changes to their positions in the company. Ameritas Investment Partners Inc. grew its position in Integral Ad Science by 92.1% during the first quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock worth $34,000 after buying an additional 1,198 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of Integral Ad Science by 493.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 8,581 shares of the company’s stock valued at $62,000 after acquiring an additional 7,135 shares during the last quarter. Amundi bought a new stake in shares of Integral Ad Science in the 4th quarter valued at about $94,000. UBS Group AG raised its position in Integral Ad Science by 119,733.3% during the 4th quarter. UBS Group AG now owns 10,785 shares of the company’s stock valued at $95,000 after purchasing an additional 10,776 shares during the last quarter. Finally, Trexquant Investment LP bought a new position in Integral Ad Science during the 3rd quarter valued at approximately $98,000. 96.39% of the stock is currently owned by institutional investors.

Integral Ad Science Price Performance

The business has a fifty day simple moving average of $18.17 and a two-hundred day simple moving average of $14.47. The company has a current ratio of 4.01, a quick ratio of 4.01 and a debt-to-equity ratio of 0.26. The stock has a market cap of $3.12 billion, a PE ratio of 201.40 and a beta of 1.57.

Integral Ad Science (NASDAQ:IASGet Free Report) last issued its earnings results on Thursday, May 4th. The company reported $0.02 EPS for the quarter, beating the consensus estimate of $0.01 by $0.01. Integral Ad Science had a return on equity of 2.17% and a net margin of 4.08%. The business had revenue of $106.09 million for the quarter, compared to the consensus estimate of $103.18 million. Research analysts forecast that Integral Ad Science Holding Corp. will post 0.12 earnings per share for the current year.

Integral Ad Science Company Profile

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Germany, Italy, Singapore, Australia, France, Japan, and India. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Recommended Stories

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.